Answers are grounded in this paper and cite their sources.
Indolent natural killer (NK)-cell lymphoproliferative disorder of the gastrointestinal tract is a rare disease that can involve single or multiple sites [1]. Patients usually present with vague gastrointestinal symptoms, including abdominal pain, vomiting, weight loss, and reflux [2]. Although this disorder is indolent, it tends to recur and persist [1]. It may be misdiagnosed as primary intestinal NK-cell lymphoma [3]. A recurrent somatic JAK3 K563_C565del mutation has been identified among 30% (3 of 10) patients [4]. Here, we report five Chinese patients with indolent NK-cell lymphoproliferative disorder and summarize the clinicopathologic features and mutational profile. Clinical information was retrieved from electronic medical records. Immunohistochemical stains for CD3, CD4, CD5, CD7, CD8, CD20, and CD56 were evaluated on endoscopic biopsy specimens. In situ hybridization for Epstein–Barr virus-encoded RNA was performed. DNA was extracted from biopsy tissues and was sequenced by using a targeted next-generation sequencing panel (Supplementary Table 1). We performed trio whole-exome sequencing for patients 1, 2, and 4 and next-generation sequencing for JAK3 K563_C565del mutation in patient 3. Sequence read alignments were completed by using NextGene V2.3.4 (Softgenetics, USA) against the human reference genome GRCh37/hg19. This study was approved by the ethical committee. We included four pediatric patients and one adult patient from two hospitals. Clinical features are summarized in Table 1. All patients had multiple gastrointestinal lesions (superficial ulcers and erosions) identified in upper and lower endoscopy (Figure 1). There was no evidence of lymphadenopathy, organomegaly, or masses among the four patients. Patient 1 was found to have cirrhosis and splenomegaly, and a small pancreas. Bone marrow aspiration identified hyperplasia and eosinophilia without signs of malignancy. Patients 1 and 2 suffered from failure to thrive. Patient 3 underwent video capsule endoscopy at 10 years old, which showed multiple jejunal and ileal ulcerations (Figure 1). Patient 4 had edema and was diagnosed with hypoalbuminemia. The adult patient presented with intermittent abdominal pain and diarrhea. Endoscopic findings in patients in this study. (A–C) Upper endoscopy findings of patient 3 showed multiple erosions in the duodenum (the first and second endoscopies, A and B) and gastric body (the third endoscopy, C). (D–F) Video capsule endoscopy showed ulcerations in the small intestine (the first and second endoscopies, D and E) and the lesion was smaller on the third endoscopy (F). (G–I) Lower endoscopy revealed ileocecal ulcerations (G), colonic ulcers (H), and ulcers with surrounding oedema (I). Summary of patients’ demographic and clinical information. NBN, c.2125A>G, p. I709V MLLT10, c.958T>C, p. S320P NBN, c.2125A>G, p. I709V MLLT10, c.958T>C, p. S320P GI = gastrointestinal, NA = not available. Summary of patients’ demographic and clinical information. NBN, c.2125A>G, p. I709V MLLT10, c.958T>C, p. S320P NBN, c.2125A>G, p. I709V MLLT10, c.958T>C, p. S320P GI = gastrointestinal, NA = not available. Histologic evaluation showed sheets of lymphoid cells in the lamina propria of the ileum. The lymphoid cells were intermediate to large in size, with irregular nuclei and pale cytoplasm. No villous atrophy, crypt hyperplasia, abscess, or distortion was identified. The muscularis mucosae were intact. Necrosis was not present. No angiocentricity or angiodestructive pattern of growth was observed. There was an absence of epitheliotropism identified in glandular epithelium. Focal increased intraepithelial lymphocytes were seen in two patients. Immunophenotypically, the cells were all positive for CD3, CD7, and CD56, and negative for CD5, CD20, and CD4 (except for partially positive in patient 4) (Supplementary Figure 1). The cells were positive for CD8 in patients 2 and 4. The T-cell receptor-γ gene rearrangement was negative in patients 1 and 2, which failed to identify evidence of a clonal process. Cytotoxic molecule-associated proteins TIA-1 and granzyme B were positive in patients 1 and 4. Moreover, the proliferation indexes assessed with Ki-67 were 60% and 30%, respectively. Epstein–Barr virus-encoded RNA was not detected in all patients. Identical somatic mutations of JAK3 K563_C565del were identified in patients 2, 3, and 4, and the variant allele frequencies were 5%, 4%, and 7%, respectively. No causative variants were identified by whole-exome sequencing in patients 1, 2, and 4. Next-generation analysis of DNA derived from peripheral blood in patient 3 detected 1% mutated allele of JAK3 K563_C565del, which confirmed the somatic mutation. Patient 1 received proton-pump inhibitors, partial enteral nutrition, and pancreatic lipase supplementation, which led to symptom improvement. However, he suffered from severe malnutrition. Patient 2 was treated with mesalamine and amino acid formula; she gained weight and her hematochezia and diarrhea improved. Patient 3 was treated with proton-pump inhibitor and partial enteral nutrition. All patients underwent at least one endoscopy and repeat endoscopy showed that the lesions persisted. Histologic analysis did not show progression to lymphoma. The average follow-up was 2.4 years. During follow-up, patient 1 was asymptomatic. Patient 2 complained of intermittent abdominal pain. Patient 3 still had vomiting without abdominal pain. Patient 4 responded to steroids, but his symptoms relapsed when prednisolone was tapered. Patient 4 improved and remained in remission on tofacitinib. Patient 5’s symptoms improved without treatment. Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract has been identified as NK-cell enteropathy in North American series and lymphomatoid gastropathy in Japanese series [1, 5–7]. As far as we know, 54 published reports have been identified (Supplementary Table 2). To our knowledge, this is the first and largest clinical and genetic analysis on Chinese patients. The majority of patients reported were middle-aged [2, 4]. The only pediatric patient presented with abdominal pain, recurrent vomiting, and failure to thrive since 6 years of age, and showed similar a disease course to patient 3 in our study [4]. Strikingly, patients 1, 2, and 4 all presented before 1 year, which had not been reported [8]. In follow-up, one patient was asymptomatic and the other two still complained of vomiting and intermittent abdominal pain. Spontaneous regression of the lesion without any treatment was identified [9]. One adult patient has been identified with spontaneous regression of disease. In contrast, pediatric patients tended to have more severe gastrointestinal presentations, endoscopic lesions, and disease course, which may be due to early the onset of the disease. We identified three patients with somatic JAK3 K563_C565del mutations, which is consistent with previous studies [4]. Xiao et al. [4] reported that the variant allele frequency ranged from 8% to 18%, while we showed that the frequency was 4%–7%. The drug targeting the JAK-STAT pathway may be promising. Patient 4 showed dramatic improvement after tofacitinib treatment without any adverse effects. However, long-term follow-up is still warranted. Indolent NK-cell proliferative lesions mimicking NK-cell lymphoma have also been reported in the vagina [10]. Several patients underwent chemotherapy because of misdiagnosis of NK/T-cell lymphoma [2, 4]. None of our patients underwent chemotherapy. The differential diagnosis is crucial and critical [1, 3]. No specific treatment is currently recommended, as symptoms and lesions can relapse. Our study reported five new cases of indolent NK-cell lymphoproliferative disorder. Our study further supported the indolent nature and recurrent JAK3 mutations associated with the disorder. Supplementary data is available at Gastroenterology Report online. This work was supported by the National Natural Science Foundation of China [grant number 82300597], Shanghai Sailing Program [grant number 22YF1403800], and Shanghai Municipal Health Commission Research Project [grant number 20224Y0283]. The authors thank all the patients and families who participated in the study. The authors declare that they have no conflicts of interest in this study.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: